4 Big Drugmakers To Bet On After A Great Earnings Season
November 15, 2019 at 08:35 AM EST
New drugs and label expansions of blockbuster drugs drove the top line of most of the big shots backed by higher demand, which countered headwinds from generic/biosimilar competition for older medicines.
